Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Edmonston

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
British Journal of Anaesthesia|May 1, 2026
Perioperative management of patients taking sodium-glucose cotransporter 2 inhibitors: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statementAdriana D Oprea, Basma Mohamed, David L Hepner, et al.
American Heart Journal|October 23, 2020
Statins and atherosclerotic cardiovascular outcomes in patients on incident dialysis and with atherosclerotic heart diseaseJay S Shavadia, Jonathan Wilson, Daniel Edmonston, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 26, 2019
Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKDDaniel Edmonston, Daniel Wojdyla, Rupal Mehta, et al.
The American Journal of Cardiology|April 19, 2024
Kidney and Cardiovascular Effectiveness of Empagliflozin Compared With Dipeptidyl Peptidase-4 Inhibitors in Patients With Type 2 DiabetesDaniel Edmonston, Hillary Mulder, Elizabeth Lydon, et al.
Journal of the American College of Cardiology|August 14, 2024
Kidney and Cardiovascular Effectiveness of SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Type 2 DiabetesDaniel Edmonston, Hillary Mulder, Elizabeth Lydon, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 22, 2020
Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United StatesJennifer E Flythe, Magdalene M Assimon, Matthew J Tugman, et al.
JAMA Network Open|June 26, 2024
Concordance With Screening and Treatment Guidelines for Chronic Kidney Disease in Type 2 DiabetesDaniel Edmonston, Elizabeth Lydon, Hillary Mulder, et al.
Blood|January 6, 2025
Glucarpidase for treatment of high-dose methotrexate toxicityShruti Gupta, Sarah A Kaunfer, Kevin L Chen, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
British Journal of Anaesthesia|May 1, 2026
Perioperative management of patients taking sodium-glucose cotransporter 2 inhibitors: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statementAdriana D Oprea, Basma Mohamed, David L Hepner, et al.
American Heart Journal|October 23, 2020
Statins and atherosclerotic cardiovascular outcomes in patients on incident dialysis and with atherosclerotic heart diseaseJay S Shavadia, Jonathan Wilson, Daniel Edmonston, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 26, 2019
Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKDDaniel Edmonston, Daniel Wojdyla, Rupal Mehta, et al.
The American Journal of Cardiology|April 19, 2024
Kidney and Cardiovascular Effectiveness of Empagliflozin Compared With Dipeptidyl Peptidase-4 Inhibitors in Patients With Type 2 DiabetesDaniel Edmonston, Hillary Mulder, Elizabeth Lydon, et al.
Journal of the American College of Cardiology|August 14, 2024
Kidney and Cardiovascular Effectiveness of SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Type 2 DiabetesDaniel Edmonston, Hillary Mulder, Elizabeth Lydon, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 22, 2020
Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United StatesJennifer E Flythe, Magdalene M Assimon, Matthew J Tugman, et al.
JAMA Network Open|June 26, 2024
Concordance With Screening and Treatment Guidelines for Chronic Kidney Disease in Type 2 DiabetesDaniel Edmonston, Elizabeth Lydon, Hillary Mulder, et al.
Blood|January 6, 2025
Glucarpidase for treatment of high-dose methotrexate toxicityShruti Gupta, Sarah A Kaunfer, Kevin L Chen, et al.
Pageof 2